BIEI (Premier Biomedical) EPS (Basic): $-0.02 (TTM As of Dec. 2019)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Premier Biomedical EPS (Basic)?

Premier Biomedical BIEI EPS (Basic) is $-0.02 as of Dec. 2019.

Premier Biomedical's basic earnings per share (Basic EPS) for the three months ended in Dec. 2019 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2019 was $-0.02.

Premier Biomedical's EPS (Diluted) for the three months ended in Dec. 2019 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2019 was $-0.02.

Premier Biomedical's EPS without NRI for the three months ended in Dec. 2019 was $-0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2019 was -0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Premier Biomedical  (OTCPK:BIEI) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Premier Biomedical EPS (Basic) Related Terms

Premier Biomedical EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Premier Biomedical's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Premier Biomedical EPS (Basic) Chart

Premier Biomedical Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only -20.00 -625.00 -1.92 -0.11 -0.01

Premier Biomedical Quarterly Data
Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.14 0.01 -0.02 -0.01 0.00

Premier Biomedical EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Premier Biomedical's Basic EPS for the fiscal year that ended in Dec. 2019 is calculated as

Basic EPS (A: Dec. 2019 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.374-0)/52.403
=-0.01

Premier Biomedical's Basic EPS for the quarter that ended in Dec. 2019 is calculated as

Basic EPS (Q: Dec. 2019 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-0.034-0)/262.111
=-0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-0.02 mean?
Premier Biomedical (BIEI) has a EPS (Basic) of $-0.02 as of Dec. 2019. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Premier Biomedical and its competitors.
Is Premier Biomedical's EPS (Basic) too high?
Premier Biomedical's current EPS (Basic) is $-0.02.
How does Premier Biomedical's EPS (Basic) compare to PTXTQ and STNN?
Premier Biomedical's EPS (Basic) of $-0.02 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Premier Biomedical and its competitors. Premier Biomedical's current EPS (Basic) is $-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Premier Biomedical stock overvalued right now?
Premier Biomedical (BIEI) has a current EPS (Basic) of $-0.02. The current EPS (Basic) is $-0.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Premier Biomedical (BIEI), the current EPS (Basic) is $-0.02 as of Dec. 2019. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Premier Biomedical Business Description

Address 1150 S. 8th Street, El Centro, CA, USA, 92243
Premier Biomedical Inc is engaged in a hemp based initiative, developing graphene enhanced formulations for a myriad of commercial and military applications and complementing new EV battery technology.